INVESTORS

AT A GLANCE

"A pioneer of digital therapeutics, Voluntis was the first such company to go public. Personally, and in the name of the entire Voluntis team, I would like to thank all of our new and historic shareholders for their faith in us. This investment of €30.1M will allow us to continue our commitment to patients and healthcare professionals, helping them better manage treatment in the hopes that this improves real-world efficacy." - Pierre Leurent, CEO of Voluntis

STOCK INFORMATION

EURONEXT Paris

WHAT'S NEW

Upcoming events

21 Mar. 2019

Full year 2018 results

CONFERENCE CALL

24 May 2019

General Meeting 2019

PARIS, FRANCE

2018 H1 Financial Report

GENERAL ASSEMBLY

General Assembly on 25 October 2018

PRESS RELEASES

DOCUMENTS

Sorry, but ther are no document, please choose other criterias

CONTACT THE INVESTOR RELATIONS TEAM

NewCap
Tristan Roquet-Montégon / Marc Willaume
21, place de la Madeleine
75008 Paris, France
Tel: +33 (0)1 44 71 94 94
Email: voluntis@newcap.eu